VEGFA and hepatocellular carcinoma: Therefore, it is biologically plausible that VEGF -2578C/A polymorphism was associated with a decreased HCC risk and the increased OS in resected HCC patients through a low serum level of VEGF caused by the 2578 C to A variant.